BNL-101（Bionaut Labs Ltd）

N/A

Report date: 2026/01/05 17:52:13

Base Information

Drug NameBNL-101（Bionaut Labs Ltd）
Drug Alias NameDoxorubicin (Bionaut Labs Ltd)BNL-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase (DNA) II alpha inhibitors
TargetsDNATopoisomerase (DNA) II alpha
Therapy Area/IndicationsDiffuse Intrinsic Pontine GliomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBionaut Labs Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionaut Labs Ltd
Inactive CompaniesN/A
Active IndicationsDiffuse Intrinsic Pontine GliomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A